Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PINNACLE: Bortezomib in Relapsed/Refractory Mantle Cell Lymphoma
NCT00063713Phase 2Completed
- Sponsor
- Millennium Pharmaceuticals
- Start
- Jun 2003
- Primary completion
- Dec 2005
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of bortezomib in mantle cell lymphoma (MCL), sponsored by Millennium Pharmaceuticals. Primary endpoint: Time to Progression. Started Jun 2003; status: completed.
02
Drugs
bortezomib
03
Conditions
mantle cell lymphoma (MCL)
Beyond the preview
Go deeper on NCT00063713.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00063713.